Exploring how young blood factors can help older individuals recover from injuries
Reparative effect of juvenile factors in aging and injury
This study is looking at whether substances from young mice can help older mice recover better from injuries by improving their cell function and reducing stress in their bodies, which could also have implications for conditions like Alzheimer's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-11041141 on NIH RePORTER |
What this research studies
This research investigates the potential benefits of circulatory factors derived from juvenile mice in improving recovery outcomes for older individuals after injuries. The study aims to understand how these juvenile factors can restore mitochondrial function and reduce oxidative stress, which are critical for healing. By using a mouse model, the researchers will test the protective effects of these juvenile-derived factors on older mice that have experienced hemorrhagic shock and assess their impact on conditions like Alzheimer's disease. The goal is to identify specific molecular factors that could revitalize aging systems and enhance recovery from injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research include older adults aged 65 and above who are at risk of injury or have experienced trauma.
Not a fit: Patients under the age of 65 or those with conditions unrelated to aging or injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery and survival rates for older patients after injuries.
How similar studies have performed: Previous research has shown promising results using juvenile-derived factors in animal models, suggesting potential for success in this novel approach.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Raju, Raghavan Pillai — Augusta University
- Study coordinator: Raju, Raghavan Pillai
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.